地佐辛用于癌症疼痛的双盲研究。

J Clin Pharmacol. 1979 Jul;19(7):392-4. doi: 10.1002/j.1552-4604.1979.tb02497.x.

A double-blind crossover comparison of intramuscularly administration of 10 mg dezocine (Wy 16225), 10 mg morphine, and placebo in ten patients with cancer pain has shown that a dezocine single dose is superior to placebo in producing relief of moderate to severe pain. No side effects were observed.

对10名癌症疼痛患者进行的一项双盲交叉比较研究，比较了肌肉注射10毫克地佐辛（Wy 16225）、10毫克吗啡和安慰剂的效果。结果显示，地佐辛单剂量在缓解中度至重度疼痛方面优于安慰剂，且未观察到副作用。